GRIA2 and central nervous system cancer: Our data indicate that F98 glioma express GluA2 roughly 50% (47–55%) of peritumoral tissue and treatment with PER, RCT or combination thereof did not affect expression levels of the AMPA receptor subunit (Figure 5B).